[HTML] frontiersin.org

[HTML][HTML] Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer

DD Singh, HJ Lee, DK Yadav - Frontiers in pharmacology, 2022 - frontiersin.org
Breast cancer (BC) is caused by epigenetic modifications and genetic heterogeneity and
exhibits various histological feature. HER2+ (Human epidermal growth factor receptor 2) is a …
被引用次数：16 相关文章
[HTML] nih.gov

[HTML][HTML] Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer

DD Singh, HJ Lee, DK Yadav - Frontiers in Pharmacology, 2022 - ncbi.nlm.nih.gov
Breast cancer (BC) is caused by epigenetic modifications and genetic heterogeneity and
exhibits various histological feature. HER2+(Human epidermal growth factor receptor 2) is a …

Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer.

DD Singh, HJ Lee, DK Yadav - Frontiers in Pharmacology, 2022 - europepmc.org
Breast cancer (BC) is caused by epigenetic modifications and genetic heterogeneity and
exhibits various histological feature. HER2+(Human epidermal growth factor receptor 2) is a …

Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer

DD Singh, HJ Lee, DK Yadav - Frontiers in pharmacology, 2022 - pubmed.ncbi.nlm.nih.gov
Breast cancer (BC) is caused by epigenetic modifications and genetic heterogeneity and
exhibits various histological feature. HER2+ (Human epidermal growth factor receptor 2) is a …

Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer

DD Singh, HJ Lee, DK Yadav - 2022 - scholarworks.bwise.kr
Breast cancer (BC) is caused by epigenetic modifications and genetic heterogeneity and
exhibits various histological feature. HER2+ (Human epidermal growth factor receptor 2) is a …

Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer

D Singh, H Lee, D Yadav - Frontiers in Pharmacology, 2022 - europepmc.org
Breast cancer (BC) is caused by epigenetic modifications and genetic heterogeneity and
exhibits various histological feature. HER2+(Human epidermal growth factor receptor 2) is a …